Mind Medicine (MNMD) Tops Q2 EPS by 7c

Mind Medicine (NASDAQ: MNMD) reported Q2 EPS of ($0.26), $0.07 better than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Mind Medicine (MNMD) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
• Worthington Industries (WOR) Misses Q4 EPS by 9c